Patient-derived Xenograft (PDX) Models are Indispensable for Newly Discovered Patient Subtypes of Pancreatic Adenocarcinoma (PDAC)

被引：0
|
作者：
Becker, C. [2 ]
Marayati, R. [1 ]
Moffitt, R. A. [1 ]
Volmar, K. E. [3 ]
Yeh, J. [1 ]
机构：
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Surg, Chapel Hill, NC USA
[3] UNC Rex Healthcare, Raleigh, NC USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P395
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [31] Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
    Inkoom, Andriana
    Ndemazie, Nkafu
    Affram, Kevin
    Smith, Taylor
    Zhu, Xue
    Underwood, Patrick
    Krishnan, Sunil
    Ofori, Edward
    Han, Bo
    Trevino, Jose
    Agyare, Edward
    INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2020, 2
  • [32] Generation and application of patient-derived xenograft models in pancreatic cancer research
    WangCheng-Fang
    ShiXian-Jie
    中华医学杂志英文版, 2019, (22) : 2729 - 2730-2731-2732-2733-2734-2735-2736
  • [33] Generation and application of patient-derived xenograft models in pancreatic cancer research
    Wang, Cheng-Fang
    Shi, Xian-Jie
    CHINESE MEDICAL JOURNAL, 2019, 132 (22) : 2729 - 2736
  • [34] Patient-derived xenograft models of BRCA-associated pancreatic cancers
    Golan, Talia
    Atias, Dikla
    Stossel, Chani
    Raitses-Gurevich, Maria
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 171 : 257 - 265
  • [35] Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma
    Torphy, Robert J.
    Tignanelli, Christopher J.
    Kamande, Joyce W.
    Moffitt, Richard A.
    Loeza, Silvia G. Herrera
    Soper, Steven A.
    Yeh, Jen Jen
    PLOS ONE, 2014, 9 (02):
  • [36] Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models
    Anastasia, Alessia
    Formenti, Laura
    Ostano, Paola
    Minoli, Lucia
    Resovi, Andrea
    Morosi, Lavinia
    Fioravanti, Claudia
    Micotti, Edoardo
    Matteo, Cristina
    Scanziani, Eugenio
    Chiorino, Giovanna
    Giavazzi, Raffaella
    Ghilardi, Carmen
    Belotti, Dorina
    MOLECULAR ONCOLOGY, 2025,
  • [37] CHARACTERIZING RESPONSE TO FOLFIRINOX IN PATIENT-DERIVED XENOGRAFT MODELS OF CLASSICAL AND BASAL-LIKE SUBTYPES OF PANCREATIC CANCER
    Bolm, Louisa
    Purschke, Birte
    Petruch, Natalie
    Ricanati, Miriam Abigail A.
    Kuo, Susan
    Warshaw, Andrew L.
    Fernandez-Del Castillo, Carlos
    Liss, Andrew S.
    GASTROENTEROLOGY, 2022, 162 (07) : S1322 - S1322
  • [38] Analysis of murine stromal components in patient derived xenograft (PDX) models of pancreatic cancer
    Behrens, D.
    Pfohl, U.
    Hallas, C.
    Buettner, B.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S59 - S60
  • [39] Patient-Derived Xenograft Models in Cancer Research
    van Weerden, Wytske M.
    CANCERS, 2021, 13 (04)
  • [40] Integrative analyses of signaling and DNA damage repair pathways in patient-derived xenograft (PDX) models from NCI's patient-derived models repository (PDMR).
    Das, Biswajit
    Evrard, Yvonne A.
    Chen, Li
    Patidar, Rajesh
    Vilimas, Tomas
    McCutcheon, Justine N.
    Peach, Amanda
    Nair, Nikitha
    Jiwani, Shahanawaz
    Borgel, Susanne
    Carter, John
    Divelbiss, Raymond
    Radzyminski, Marianne
    Stottlemyer, Jesse
    Ju, Zhenlin
    Akbani, Rehan
    Karlovich, Chris Alan
    Williams, Paul M.
    Hollingshead, Melinda G.
    Doroshow, James H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345